Dr. Reddy's Laboratories Ltd. closed 15.53% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...

Rarely we see rich and famous entrepreneurs with as big a heart as that of the late and legendry Ratan Tata. Such people do ...

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...

A recent CDC study said greater access to fertility treatments and more education for teens have led to a role reversal in ...

Dr. Reddy's Laboratories Ltd. closed 17.37% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr Reddys Laboratories' shares reflect a positive movement amid high trading volumes during today's session. The company's ...

Dr Reddy’s and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.

Uncertainties around US tariffs and the end of the limited competition period for generic Revlimid in the US will loom in ...

NDTV Profit reports dealer chatter suggesting a potential Carlyle exit from PNB Housing, an imminent Axis Bank QIP, and ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used ...

Apollo Diagnostics launches cutting-edge Digi-Smart Central Reference Laboratory in Chennai, offering faster, more accurate ...